Compare Centene Corp (CNC) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Nomura Holdings Inc — how do they compare? Centene Corp trades at $68.55 (market cap $33.72B), while Nomura Holdings Inc trades at $10.02 (market cap $27.87B). The key difference: Centene Corp is the larger of the two by market cap, and Nomura Holdings Inc pays a 3.37% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | NMR | |
|---|---|---|
Market Cap | $33.72B | $27.87B |
Sector | Health | Financials |
52-Week High | $68.72 | $9.75 |
52-Week Low | $25.21 | $6.30 |
Enterprise Value | $26.35B | — |
Dividend Yield | — | 3.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
